Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Amelia Pilar Rauter

Amelia Pilar Rauter

University of Lisbon, Portugal

Title: Glycan synthesis towards new glycolipid antibiotics with new mechanisms of action

Biography

Biography: Amelia Pilar Rauter

Abstract

The search for new antimicrobial drugs is currently one of the major ongoing research areas due to the spread of multidrug-resistance, thus encouraging research on antibacterial agents with new mechanisms of action. A new family of antibiotics, structurally based on glycolipids, with a potent antimicrobial activity against Bacillus species will be disclosed. We present our recent findings that cover synthetic approaches to new antimicrobial molecular entities differing in the glycon structure, based on alkyl deoxy pento- and hexopyranosides belonging to the D- or L-series. Stereochemistry, in particular the anomeric configuration, and the deoxygenation pattern are modified in order to evaluate their contribution to the structure/activity relationship. Also the lipophilic chain is changed for the recognition of the key structural features for the bioactivity/selectivity for Bacillus species. The surface properties of the most active compounds, in terms of adsorption and aggregation parameters, are also presented. Although surface activity is required for the bioactivity, this property is not sufficient to account for bioactivity, as shown by some promising surface active glycosides, that were not active. In order to have insights into the mechanism of action of this family of compounds, expected to target bacterial membranes, a multidisciplinary approach covering biophysical and biological methods was followed. The elucidation of the new mechanisms of action of this family of antibiotics will be disclosed and discussed, demonstrating the relevance of the glycan structure for the bactericidal activity.